Leukemia Treatment EPZ-5676 Cas Number 1380288-87-8

Unit Price: USD 100.0000 / Kilogram
Payment Type: L/C,T/T
Incoterm: CIF
Min. Order: 1 Kilogram
Delivery Time: 3 Days

Basic Info

Model No.: 1380288-87-8

Additional Info

Packaging: 25KGS/DRUM

Productivity: 30T/Y


Transportation: Ocean,Land,Air

Place of Origin: CHINA

Supply Ability: 30T/Y

Certificate: YES

Product Description

EPZ-5676 CAS number is 1380288-87-8, a new drug for the treatment of a rare subtype of leukemia EPZ-5676 is recognized by the FDA as a rare disease. The drug is currently in Phase I clinical studies. Affected by this news, the company's stock price also rose.EPZ-5676 CAS number 1380288-87-8 is an inhibitor of an enzyme called DOT1L. DOT1L plays an important role in the pathogenesis of mixed cell line leukemia. Epizyme has authorized Celgene to own the EPZ-5676 sales rights outside the US market.
According to the FDA's rules for rare disease medications, diseases with a patient count of less than 200,000 can be defined as rare diseases, compared with approximately 5,000 patients with mixed cell line leukemia. Epizyme's EPZ-5676 study will receive a series of preferential measures such as tax cuts after qualifying for the rare disease drug.
    EP-5676 is a competitive inhibitor of S-adenosylmethionine (SAM) of protein methyltransferase DOT1L with a Ki of 80 pM, which is more than 37,000 more selective than all other PMTs, inhibiting tumor H3K79 methylation. . Phase 1.EPZ-5676 reduced H3K79 dimethylation in MV4-11 cells with an IC50 of 2.6 nM. EPZ-5676 reduces H3K79 methylation in a concentration- and time-dependent manner, but has no effect on other histone sites, which results in a MLL gene and selective apoptotic cell killing of key targets that are inhibited in MLL rearranged leukemia cells. EPZ-5676 inhibited the proliferation of the MLL-AF4 rearranged cell line MV4-11 with an IC50 of 9 nM.
    In a MLL rearranged leukemia xenograft model, EPZ-5676 resulted in a dose-dependent anti-tumor activity after a continuous intravenous infusion for 21 days. At the highest dose of 70.5 mg / kg / day, the treatment stopped after the tumor completely resolved, and there was no tumor regrowth for up to 32 days. No significant weight loss or significant toxicity occurred in the EPZ-5676 treated rats.

Thera. Category:Anti-cancer

Cas No.:  1380288-87-8


Molecular Formula:C30H42N8O3


Molecular Weight:562.70628

Pharmacopeia: in house spe.

Specifications:Available on request

Packing:Export worthy packing

Material Safety Data Sheet:Available on request


Active Pharmaceutical Ingredients> Cas 90098-04-7,Rebamipide Named In Mucosta With GMP Standard
Active Pharmaceutical Ingredients> Functional Dyspepsia Treatment Acotiamide Hydrochloride Trihydrate CAS 773092-05-0
Active Pharmaceutical Ingredients> Acotiamide Hydrochloride For Gastric Motility Improvement CAS 185104-11-4
Contract Manufacturing> ASCORBYL GLUCOSIDE Used for Comesitc Additive CAS 129499-78-1
Pharmaceutical Intermediates> Anti-Ulcerative> 2-Aminothiazole-4-ethylformate For Making Acotiamide Cas 5398-36-7
Pharmaceutical Intermediates> Anti-Ulcerative> Acotiamide INT CAS NUMBER 185105-98-0
Pharmaceutical Intermediates> Anti-Cardiovascular> Azilsartan Used for Hypertension Treatment CAS 147403-03-0
Pharmaceutical Intermediates> Anti-Diabetes> Sitagliptin Phosphate Monohydrate Treated for Type 2 diabetes CAS Number 654671-77-9
Pharmaceutical Intermediates> Anti-Ulcerative> Cas 132210-24-3, 2-Amino-3-(1,2-dihydro-2-oxo-quinoline-4-yl)Propanoic acid Hydrochloride For Rebamipide
Pharmaceutical Intermediates> Anti-Ulcerative> Cas 1068-90-2 White Crystalline Powder Diethyl Acetamidomalonate For Rebamipide(DAAM)
Active Pharmaceutical Ingredients> 6027-23-2, Hordenine HCL Powder
Pharmaceutical Intermediates> Anti-Ulcerative> Cas 4876-10-2,4-Bromomethyl-2(1H)-quinolinone (BMQ) For Rebamipide/ Mucosta
Pharmaceutical Intermediates> Anti-Respiratory> CAS 2338-18-3, 2-Aminoindan hydrochloride For Making Indacaterol
Pharmaceutical Intermediates> Anti-Respiratory> CAS 312753-53-0/ 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride Used for Indacaterol
Pharmaceutical Intermediates> Anti-Respiratory> 312753-53-0, Indacaterol Intermediate
Pharmaceutical Intermediates> Anti-Respiratory> 100331-89-3, Indacaterol Intermediate

© 2019 CHINA WAY. All Rights Reserved.  Taizhou Volsen Chemical Co., Ltd.,  Inc.   All rights reserved. site map.  sitemap.html